Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis-Reference-Cited by-同舟云学术

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Published:2016-07-15 Issue:12 Volume:30 Page:2342-2350
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Jawhar M,Schwaab J,Hausmann D,Clemens J,Naumann N,Henzler T,Horny H-P,Sotlar K,Schoenberg S O,Cross N C P,Fabarius A,Hofmann W-K,Valent P,Metzgeroth G,Reiter A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016190.pdf

Reference23 articles.

1. Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435–453.

2. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603–625.

3. Pardanani A . Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management. Am J Hematol 2013; 88: 612–624.

4. Theoharides TC, Valent P, Akin C . Mast cells, mastocytosis, and related disorders. New Engl J Med 2015; 373: 163–172.

5. Pardanani A . Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol 2015; 90: 250–262.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM;Blood Advances;2024-06-05

2. Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis;Journal of Hematology;2024-06

3. SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis;Clinical Lymphoma Myeloma and Leukemia;2024-06

4. Histological characterization of liver involvement in systemic mastocytosis;Liver International;2024-03-30

5. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries;Leukemia;2024-03-06